Screener
AbCellera Biologics Inc. ABCL Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
| Line item | December 31, 2025 | June 30, 2026 |
|---|---|---|
| Accounts and accrued receivable | 58,293 | 18,597 |
| Restricted cash | 25,000 | 25,000 |
| Other current assets | 111,113 | 95,529 |
| Total current assets | 728,232 | 679,230 |
| Long-term assets: | ||
| Property and equipment, net | 428,003 | 416,677 |
| Intangible assets, net | 38,381 | 36,530 |
| Goodwill | 47,806 | 47,806 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is AbCellera Biologics Inc.'s total current assets?
- AbCellera Biologics Inc. (ABCL) reported total current assets of $679.23M in Q2 2026.
- How has AbCellera Biologics Inc.'s total current assets changed year-over-year?
- AbCellera Biologics Inc.'s total current assets decreased by 8.5% year-over-year, from $742.15M to $679.23M.
- What is the long-term trend for AbCellera Biologics Inc.'s total current assets?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s total current assets has grown at a -2.2% compound annual growth rate (CAGR), from $813.33M to $728.23M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about AbCellera Biologics Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude